$OFIX
Orthofix Medical Inc.

2016 Q1 Form 10-Q Financial Statement

#000156459016016963 Filed on April 28, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $98.68M $89.76M
YoY Change 9.93% -10.25%
Cost Of Revenue $22.14M $19.34M
YoY Change 14.47% -27.77%
Gross Profit $76.54M $70.42M
YoY Change 8.69% -3.85%
Gross Profit Margin 77.57% 78.46%
Selling, General & Admin $61.83M $65.85M
YoY Change -6.12% 7.23%
% of Gross Profit 80.78% 93.51%
Research & Development $7.640M $5.845M
YoY Change 30.71% -1.58%
% of Gross Profit 9.98% 8.3%
Depreciation & Amortization $4.900M $400.0K
YoY Change 1125.0% -93.34%
% of Gross Profit 6.4% 0.57%
Operating Expenses $69.47M $77.62M
YoY Change -10.5% 5.93%
Operating Profit $7.075M -$7.192M
YoY Change -198.37% 24700.0%
Interest Expense $0.00 $272.0K
YoY Change -100.0% -41.88%
% of Operating Profit 0.0%
Other Income/Expense, Net $1.795M $419.0K
YoY Change 328.4% -156.62%
Pretax Income $8.870M -$6.773M
YoY Change -230.96% 780.75%
Income Tax $4.294M $964.0K
% Of Pretax Income 48.41%
Net Earnings $3.840M -$8.379M
YoY Change -145.83% 234.09%
Net Earnings / Revenue 3.89% -9.33%
Basic Earnings Per Share $0.21 -$0.45
Diluted Earnings Per Share $0.20 -$0.45
COMMON SHARES
Basic Shares Outstanding 18.48M 18.73M
Diluted Shares Outstanding 18.76M 18.73M

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.80M $29.80M
YoY Change 33.56% 18.73%
Cash & Equivalents $39.85M $29.78M
Short-Term Investments
Other Short-Term Assets $19.00M $90.00M
YoY Change -78.89% -0.44%
Inventory $59.80M $56.70M
Prepaid Expenses
Receivables $55.30M $58.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $174.0M $235.0M
YoY Change -25.96% -15.6%
LONG-TERM ASSETS
Property, Plant & Equipment $53.60M $46.70M
YoY Change 14.78% -11.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $76.00M $45.50M
YoY Change 67.03% 574.77%
Total Long-Term Assets $188.8M $151.7M
YoY Change 24.46% 20.83%
TOTAL ASSETS
Total Short-Term Assets $174.0M $235.0M
Total Long-Term Assets $188.8M $151.7M
Total Assets $362.8M $386.7M
YoY Change -6.18% -4.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.50M $16.30M
YoY Change -17.18% 16.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.00M $69.40M
YoY Change -14.99% 25.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $28.30M $26.80M
YoY Change 5.6% 114.62%
Total Long-Term Liabilities $28.30M $26.80M
YoY Change 5.6% 114.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.00M $69.40M
Total Long-Term Liabilities $28.30M $26.80M
Total Liabilities $87.30M $96.20M
YoY Change -9.25% -6.97%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $275.5M $290.5M
YoY Change
Total Liabilities & Shareholders Equity $362.8M $386.7M
YoY Change -6.18% -4.28%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $3.840M -$8.379M
YoY Change -145.83% 234.09%
Depreciation, Depletion And Amortization $4.900M $400.0K
YoY Change 1125.0% -93.34%
Cash From Operating Activities $4.646M $2.543M
YoY Change 82.7% -124.93%
INVESTING ACTIVITIES
Capital Expenditures $6.083M $5.074M
YoY Change 19.89% 37.47%
Acquisitions
YoY Change
Other Investing Activities $1.000M -$10.50M
YoY Change -109.52%
Cash From Investing Activities -$7.399M -$15.56M
YoY Change -52.46% 320.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.71M $1.710M
YoY Change 1110.99% -69.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -21.72M 8.938M
YoY Change -343.03% -11.5%
NET CHANGE
Cash From Operating Activities 4.646M 2.543M
Cash From Investing Activities -7.399M -15.56M
Cash From Financing Activities -21.72M 8.938M
Net Change In Cash -24.48M -4.082M
YoY Change 499.58% 7.42%
FREE CASH FLOW
Cash From Operating Activities $4.646M $2.543M
Capital Expenditures $6.083M $5.074M
Free Cash Flow -$1.437M -$2.531M
YoY Change -43.22% -81.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
98679000
CY2016Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22136000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44816000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44285000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16718000
CY2015Q1 ofix Marketing Service Fees
MarketingServiceFees
12930000
CY2016Q1 ofix Marketing Service Fees
MarketingServiceFees
13054000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21569000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7636000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5845000
CY2016Q1 ofix Restatements And Related Costs
RestatementsAndRelatedCosts
245000
CY2015Q1 ofix Restatements And Related Costs
RestatementsAndRelatedCosts
5916000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
69415000
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18477881
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18731985
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18731985
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18749401
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7128000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7192000
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-272000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1833000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
691000
CY2016Q1 us-gaap Gross Profit
GrossProfit
76543000
CY2015Q1 us-gaap Gross Profit
GrossProfit
70423000
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19339000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
77615000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
419000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8923000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6773000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4294000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
964000
CY2016Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4629000
CY2015Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7737000
CY2016Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-990000
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-781000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1795000
CY2016Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-254000
CY2015Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-139000
CY2016Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-736000
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-642000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
3893000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-8379000
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.41
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.25
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.41
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
CY2016Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
26000
CY2015Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
665000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-527000
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1221000
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4860000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4613000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12574000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4424000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2543000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6083000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5074000
CY2016Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
316000
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
39000
CY2016Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
1000000
CY2015Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
15250000
CY2015Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4800000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7399000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15563000
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4742000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1710000
CY2015Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
7171000
CY2016Q1 ofix Repurchase And Retirement Of Common Shares
RepurchaseAndRetirementOfCommonShares
26464000
CY2016Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
222000
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
57000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21500000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8938000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
658000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2949000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23817000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7031000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36815000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29784000
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2016Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2016Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6600000
CY2016Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5800000
CY2015Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6300000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
271520
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1800000
CY2016Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3923000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4976000
CY2016Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5593000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5087000
CY2016Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
46066000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42947000
CY2016Q1 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
4205000
CY2015Q4 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
4553000
CY2016Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
203398
CY2015Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
145866
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.481
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.142
CY2016Q1 ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Items
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteItems
0.463
CY2015Q1 ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Items
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteItems
0.092
CY2016Q1 ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
0.099
CY2016Q1 ofix Percentage Of Constant Currency Increase Decrease
PercentageOfConstantCurrencyIncreaseDecrease
0.118
CY2016Q1 ofix Net Margin
NetMargin
31727000
CY2015Q1 ofix Net Margin
NetMargin
26138000
CY2015Q4 ofix Accrued Settlement Costs
AccruedSettlementCosts
300000
CY2016Q1 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
1300000
CY2016Q1 ofix Accrued Expenses And Other Liabilities Related To Discontinued Operation
AccruedExpensesAndOtherLiabilitiesRelatedToDiscontinuedOperation
6000000
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2016Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
676259
CY2016Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
26500000
CY2016Q1 ofix Average Price Paid Per Share
AveragePricePaidPerShare
39.13
CY2016Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
37000000

Files In Submission

Name View Source Status
0001564590-16-016963-index-headers.html Edgar Link pending
0001564590-16-016963-index.html Edgar Link pending
0001564590-16-016963.txt Edgar Link pending
0001564590-16-016963-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ofix-10q_20160331.htm Edgar Link pending
ofix-20160331.xml Edgar Link completed
ofix-20160331.xsd Edgar Link pending
ofix-20160331_cal.xml Edgar Link unprocessable
ofix-20160331_def.xml Edgar Link unprocessable
ofix-20160331_lab.xml Edgar Link unprocessable
ofix-20160331_pre.xml Edgar Link unprocessable
ofix-ex102_22.htm Edgar Link pending
ofix-ex103_97.htm Edgar Link pending
ofix-ex104_98.htm Edgar Link pending
ofix-ex105_99.htm Edgar Link pending
ofix-ex311_7.htm Edgar Link pending
ofix-ex312_6.htm Edgar Link pending
ofix-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending